Kymera Therapeutics, Inc. (KYMR) Q3 2026 Earnings Name Transcript
Firm Contributors
Justine Koenigsberg – Vice President of Investor Relations
Nello Mainolfi – Co-Founder, President, CEO & Director
Terence Rooney – Chief Medical Officer
Bruce Jacobs – Chief Monetary Officer
Convention Name Contributors
Lut Ming Cheng
Thomas Smith – Leerink Companions LLC, Analysis Division
Derek Archila – Wells Fargo Securities, LLC, Analysis Division
Michael Ulz – Morgan Stanley, Analysis Division
Biren Amin – Piper Sandler & Co., Analysis Division
Alexander Thompson – Stifel, Nicolaus & Firm, Included, Analysis Division
Faisal Khurshid – Jefferies LLC, Analysis Division
Jeffrey Jones – Oppenheimer & Co. Inc., Analysis Division
Kevin Meli – RBC Capital Markets, Analysis Division
Morgan Lamberti – Goldman Sachs Group, Inc., Analysis Division
David Hoang – Deutsche Financial institution AG, Analysis Division
Tyler Van Buren – Cowen Inc.
Jeet Mukherjee – BTIG, LLC, Analysis Division
Jasmine Fels – Barclays Financial institution PLC, Analysis Division
Seamus Fernandez – Guggenheim Securities, LLC, Analysis Division
Tazeen Ahmad – BofA Securities, Analysis Division
Xiaochuan Dai – UBS Funding Financial institution, Analysis Division
Srikripa Devarakonda – Truist Securities, Inc., Analysis Division
Joseph Holden – Canaccord Genuity Corp., Analysis Division
Presentation
Operator
Good day, everybody. My title is Michelle, and I will likely be your convention operator in the present day. Presently, I want to welcome you to the Kymera Therapeutics Third Quarter 2026 Outcomes Name. [Operator Instructions] Presently, I want to flip the decision over to Justine Koenigsberg, Vice President of Investor Relations. Justine, please go forward.
Justine Koenigsberg
Vice President of Investor Relations
Good morning, and welcome to Kymera’s quarterly replace name, which may even embody a dialogue of the KT-579 Part I Wholesome Volunteer outcomes. Becoming a member of me this morning with ready remarks are Nello Mainolfi, our Founder, President and CEO; Terence Rooney, our Chief Medical Officer; and Bruce Jacobs, our Chief Monetary Officer.
Following our ready remarks, we are going to open the
